Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans

Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans

Laishun Chen, William M Greenberg, Elimor Brand-Schieber, Julie Wangsa, Antonia Periclou, Parviz Ghahramani Forest Research Institute, a subsidiary of Actavis Inc., Jersey City, NJ, USA Purpose: Levomilnacipran extended-release (ER) is indicated for treatment of major depressive disorder in adults...

Full description

Bibliographic Details
Main Authors: Chen L, Greenberg WM, Brand-Schieber E, Wangsa J, Periclou A, Ghahramani P
Format: Article
Language:English
Published: Dove Medical Press 2015-06-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/effect-of-renal-impairment-on-the-pharmacokinetics-of-levomilnacipran--peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/effect-of-renal-impairment-on-the-pharmacokinetics-of-levomilnacipran--peer-reviewed-article-DDDT

Similar Items